 | • レポートコード：20QY06-08458 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、本態性血小板血症治療薬のグローバル市場について種類別（ジビノスタット、イダサヌトリン、プラシノスタット、リン酸ルキソリチニブ、その他）、用途別（研究センター、病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・本態性血小板血症治療薬市場の概要 ・世界の主要地域別本態性血小板血症治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の本態性血小板血症治療薬市場規模2015-2026：種類別（ジビノスタット、イダサヌトリン、プラシノスタット、リン酸ルキソリチニブ、その他） ・世界の本態性血小板血症治療薬市場規模2015-2026：用途別（研究センター、病院、クリニック、その他） ・本態性血小板血症治療薬の北米市場規模2015-2020 ・本態性血小板血症治療薬のヨーロッパ市場規模2015-2020 ・本態性血小板血症治療薬の中国市場規模2015-2020 ・本態性血小板血症治療薬の日本市場規模2015-2020 ・本態性血小板血症治療薬の東南アジア市場規模2015-2020 ・本態性血小板血症治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AbbVie Inc、Aop Orphan Pharmaceuticals AG、F. Hoffmann-La Roche Ltd、Galena Biopharma Inc、Incyte Corp、Italfarmaco SpA、MEI Pharma Inc、PharmaEssentia Corp） ・本態性血小板血症治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・本態性血小板血症治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Essential Thrombocythemia Drug Market
The global Essential Thrombocythemia Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Essential Thrombocythemia Drug Scope and Market Size
The global Essential Thrombocythemia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Essential Thrombocythemia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Essential Thrombocythemia Drug market is segmented into
Givinostat
Idasanutlin
Pracinostat
Ruxolitinib Phosphate
Others
Segment by Application, the Essential Thrombocythemia Drug market is segmented into
Research Center
Hospital
Clinic
Others
The Essential Thrombocythemia Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Essential Thrombocythemia Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Essential Thrombocythemia Drug Market Share Analysis
Essential Thrombocythemia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Essential Thrombocythemia Drug business, the date to enter into the Essential Thrombocythemia Drug market, Essential Thrombocythemia Drug product introduction, recent developments, etc.
The major vendors covered:
AbbVie Inc
Aop Orphan Pharmaceuticals AG
F. Hoffmann-La Roche Ltd
Galena Biopharma Inc
Incyte Corp
Italfarmaco SpA
MEI Pharma Inc
PharmaEssentia Corp
Table of Contents
1 Essential Thrombocythemia Drug Market Overview
1.1 Essential Thrombocythemia Drug Product Scope
1.2 Essential Thrombocythemia Drug Segment by Type
1.2.1 Global Essential Thrombocythemia Drug Sales by Type (2020-2026)
1.2.2 Givinostat
1.2.3 Idasanutlin
1.2.4 Pracinostat
1.2.5 Ruxolitinib Phosphate
1.2.6 Others
1.3 Essential Thrombocythemia Drug Segment by Application
1.3.1 Global Essential Thrombocythemia Drug Sales Comparison by Application (2020-2026)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Essential Thrombocythemia Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Essential Thrombocythemia Drug Sales Growth Rate (2015-2026)
1.4.2 Global Essential Thrombocythemia Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Essential Thrombocythemia Drug Price Trends (2015-2026)
2 Essential Thrombocythemia Drug Estimate and Forecast by Region
2.1 Global Essential Thrombocythemia Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Essential Thrombocythemia Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Essential Thrombocythemia Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Essential Thrombocythemia Drug Revenue Market Share by Region (2015-2020)
2.3 Global Essential Thrombocythemia Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Essential Thrombocythemia Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Essential Thrombocythemia Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Essential Thrombocythemia Drug Estimates and Projections (2015-2026)
2.4.2 Europe Essential Thrombocythemia Drug Estimates and Projections (2015-2026)
2.4.3 China Essential Thrombocythemia Drug Estimates and Projections (2015-2026)
2.4.4 Japan Essential Thrombocythemia Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Essential Thrombocythemia Drug Estimates and Projections (2015-2026)
2.4.6 India Essential Thrombocythemia Drug Estimates and Projections (2015-2026)
3 Global Essential Thrombocythemia Drug Competition Landscape by Players
3.1 Global Top Essential Thrombocythemia Drug Players by Sales (2015-2020)
3.2 Global Top Essential Thrombocythemia Drug Players by Revenue (2015-2020)
3.3 Global Essential Thrombocythemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Essential Thrombocythemia Drug as of 2019)
3.4 Global Essential Thrombocythemia Drug Average Price by Company (2015-2020)
3.5 Manufacturers Essential Thrombocythemia Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Essential Thrombocythemia Drug Players (Opinion Leaders)
4 Global Essential Thrombocythemia Drug Market Size by Type
4.1 Global Essential Thrombocythemia Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Essential Thrombocythemia Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Essential Thrombocythemia Drug Price by Type (2014-2020)
4.2 Global Essential Thrombocythemia Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Essential Thrombocythemia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Essential Thrombocythemia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Essential Thrombocythemia Drug Price Forecast by Type (2021-2026)
5 Global Essential Thrombocythemia Drug Market Size by Application
5.1 Global Essential Thrombocythemia Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Essential Thrombocythemia Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Essential Thrombocythemia Drug Price by Application (2015-2020)
5.2 Global Essential Thrombocythemia Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Essential Thrombocythemia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Essential Thrombocythemia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Essential Thrombocythemia Drug Price Forecast by Application (2021-2026)
3 North America Essential Thrombocythemia Drug Market Facts & Figures
3.2 North America Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
3.3 North America Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
3.4 North America Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
4 Europe Essential Thrombocythemia Drug Market Facts & Figures
4.2 Europe Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
4.3 Europe Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
4.4 Europe Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
5 China Essential Thrombocythemia Drug Market Facts & Figures
5.2 China Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
5.3 China Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
5.4 China Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
6 Japan Essential Thrombocythemia Drug Market Facts & Figures
6.2 Japan Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
6.3 Japan Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
6.4 Japan Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Essential Thrombocythemia Drug Market Facts & Figures
7.2 Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
8 India Essential Thrombocythemia Drug Market Facts & Figures
8.2 India Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
8.3 India Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
8.4 India Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Essential Thrombocythemia Drug Business
12.1 AbbVie Inc
12.1.1 AbbVie Inc Essential Thrombocythemia Drug Corporation Information
12.1.2 AbbVie Inc Essential Thrombocythemia Drug Business Overview and Total Revenue
12.1.3 AbbVie Inc Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Inc Essential Thrombocythemia Drug Products Offered
12.1.5 AbbVie Inc Recent Development
12.2 Aop Orphan Pharmaceuticals AG
12.2.1 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Corporation Information
12.2.2 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Business Overview and Total Revenue
12.2.3 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Products Offered
12.2.5 Aop Orphan Pharmaceuticals AG Recent Development
12.3 F. Hoffmann-La Roche Ltd
12.3.1 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Corporation Information
12.3.2 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Business Overview and Total Revenue
12.3.3 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Products Offered
12.3.5 F. Hoffmann-La Roche Ltd Recent Development
12.4 Galena Biopharma Inc
12.4.1 Galena Biopharma Inc Essential Thrombocythemia Drug Corporation Information
12.4.2 Galena Biopharma Inc Essential Thrombocythemia Drug Business Overview and Total Revenue
12.4.3 Galena Biopharma Inc Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Galena Biopharma Inc Essential Thrombocythemia Drug Products Offered
12.4.5 Galena Biopharma Inc Recent Development
12.5 Incyte Corp
12.5.1 Incyte Corp Essential Thrombocythemia Drug Corporation Information
12.5.2 Incyte Corp Essential Thrombocythemia Drug Business Overview and Total Revenue
12.5.3 Incyte Corp Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Incyte Corp Essential Thrombocythemia Drug Products Offered
12.5.5 Incyte Corp Recent Development
12.6 Italfarmaco SpA
12.6.1 Italfarmaco SpA Essential Thrombocythemia Drug Corporation Information
12.6.2 Italfarmaco SpA Essential Thrombocythemia Drug Business Overview and Total Revenue
12.6.3 Italfarmaco SpA Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Italfarmaco SpA Essential Thrombocythemia Drug Products Offered
12.6.5 Italfarmaco SpA Recent Development
12.7 MEI Pharma Inc
12.7.1 MEI Pharma Inc Essential Thrombocythemia Drug Corporation Information
12.7.2 MEI Pharma Inc Essential Thrombocythemia Drug Business Overview and Total Revenue
12.7.3 MEI Pharma Inc Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MEI Pharma Inc Essential Thrombocythemia Drug Products Offered
12.7.5 MEI Pharma Inc Recent Development
12.8 PharmaEssentia Corp
12.8.1 PharmaEssentia Corp Essential Thrombocythemia Drug Corporation Information
12.8.2 PharmaEssentia Corp Essential Thrombocythemia Drug Business Overview and Total Revenue
12.8.3 PharmaEssentia Corp Essential Thrombocythemia Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 PharmaEssentia Corp Essential Thrombocythemia Drug Products Offered
12.8.5 PharmaEssentia Corp Recent Development
13 Essential Thrombocythemia Drug Manufacturing Cost Analysis
13.1 Essential Thrombocythemia Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Essential Thrombocythemia Drug
13.4 Essential Thrombocythemia Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Essential Thrombocythemia Drug Distributors List
14.3 Essential Thrombocythemia Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Essential Thrombocythemia Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Essential Thrombocythemia Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Essential Thrombocythemia Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Essential Thrombocythemia Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Essential Thrombocythemia Drug Sales Market Share by Region (2015-2020)
Table 6. Global Essential Thrombocythemia Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Essential Thrombocythemia Drug Revenue Share by Region (2015-2020)
Table 8. Global Essential Thrombocythemia Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Essential Thrombocythemia Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Essential Thrombocythemia Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Essential Thrombocythemia Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Essential Thrombocythemia Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Essential Thrombocythemia Drug Sales Share by Company (2015-2020)
Table 14. Global Essential Thrombocythemia Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Essential Thrombocythemia Drug Revenue Share by Company (2015-2020)
Table 16. Global Essential Thrombocythemia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Essential Thrombocythemia Drug as of 2019)
Table 17. Global Essential Thrombocythemia Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Essential Thrombocythemia Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Essential Thrombocythemia Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Essential Thrombocythemia Drug Players
Table 22. Global Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Essential Thrombocythemia Drug Sales Share by Type (2015-2020)
Table 24. Global Essential Thrombocythemia Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Essential Thrombocythemia Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Essential Thrombocythemia Drug Sales Share by Type (2021-2026)
Table 27. Global Essential Thrombocythemia Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Essential Thrombocythemia Drug Revenue Share by Type (2021-2026)
Table 29. Global Essential Thrombocythemia Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Essential Thrombocythemia Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Essential Thrombocythemia Drug Sales Share by Application (2015-2020)
Table 32. Global Essential Thrombocythemia Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Essential Thrombocythemia Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Essential Thrombocythemia Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Essential Thrombocythemia Drug Sales Share by Application (2021-2026)
Table 36. Global Essential Thrombocythemia Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Essential Thrombocythemia Drug Revenue Share by Application (2021-2026)
Table 38. Global Essential Thrombocythemia Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Essential Thrombocythemia Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
Table 41. United States Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 43. United States Essential Thrombocythemia Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Essential Thrombocythemia Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Essential Thrombocythemia Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 51. China Essential Thrombocythemia Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
Table 53. China Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 55. China Essential Thrombocythemia Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Essential Thrombocythemia Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Essential Thrombocythemia Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Essential Thrombocythemia Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
Table 69. India Essential Thrombocythemia Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Essential Thrombocythemia Drug Sales Market Share by Company (2015-2020)
Table 71. India Essential Thrombocythemia Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Essential Thrombocythemia Drug Sales Market Share by Type (2015-2020)
Table 73. India Essential Thrombocythemia Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Essential Thrombocythemia Drug Sales Market Share by Application (2015-2020)
Table 75. AbbVie Inc Corporation Information
Table 76. AbbVie Inc Description and Business Overview
Table 77. AbbVie Inc Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AbbVie Inc Essential Thrombocythemia Drug Product
Table 79. AbbVie Inc Recent Development
Table 80. Aop Orphan Pharmaceuticals AG Corporation Information
Table 81. Aop Orphan Pharmaceuticals AG Description and Business Overview
Table 82. Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Product
Table 84. Aop Orphan Pharmaceuticals AG Recent Development
Table 85. F. Hoffmann-La Roche Ltd Corporation Information
Table 86. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 87. F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Product
Table 89. F. Hoffmann-La Roche Ltd Recent Development
Table 90. Galena Biopharma Inc Corporation Information
Table 91. Galena Biopharma Inc Description and Business Overview
Table 92. Galena Biopharma Inc Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Galena Biopharma Inc Essential Thrombocythemia Drug Product
Table 94. Galena Biopharma Inc Recent Development
Table 95. Incyte Corp Corporation Information
Table 96. Incyte Corp Description and Business Overview
Table 97. Incyte Corp Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Incyte Corp Essential Thrombocythemia Drug Product
Table 99. Incyte Corp Recent Development
Table 100. Italfarmaco SpA Corporation Information
Table 101. Italfarmaco SpA Description and Business Overview
Table 102. Italfarmaco SpA Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Italfarmaco SpA Essential Thrombocythemia Drug Product
Table 104. Italfarmaco SpA Recent Development
Table 105. MEI Pharma Inc Corporation Information
Table 106. MEI Pharma Inc Description and Business Overview
Table 107. MEI Pharma Inc Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. MEI Pharma Inc Essential Thrombocythemia Drug Product
Table 109. MEI Pharma Inc Recent Development
Table 110. PharmaEssentia Corp Corporation Information
Table 111. PharmaEssentia Corp Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. PharmaEssentia Corp Description and Business Overview
Table 113. PharmaEssentia Corp Essential Thrombocythemia Drug Product
Table 114. PharmaEssentia Corp Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Essential Thrombocythemia Drug Distributors List
Table 118. Essential Thrombocythemia Drug Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Essential Thrombocythemia Drug Product Picture
Figure 2. Global Essential Thrombocythemia Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Essential Thrombocythemia Drug Market Share by Application in 2020 & 2026
Figure 6. Research Center Examples
Figure 7. Hospital Examples
Figure 8. Clinic Examples
Figure 9. Others Examples
Figure 10. Global Essential Thrombocythemia Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Essential Thrombocythemia Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Essential Thrombocythemia Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Essential Thrombocythemia Drug Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Essential Thrombocythemia Drug Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Essential Thrombocythemia Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Essential Thrombocythemia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Essential Thrombocythemia Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Essential Thrombocythemia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Essential Thrombocythemia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Essential Thrombocythemia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Essential Thrombocythemia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Essential Thrombocythemia Drug Players Market Share by Revenue in Essential Thrombocythemia Drug 2015 & 2019
Figure 28. Essential Thrombocythemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Essential Thrombocythemia Drug Revenue Share by Type (2015-2020)
Figure 30. Global Essential Thrombocythemia Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Essential Thrombocythemia Drug Revenue Share by Application (2015-2020)
Figure 32. Global Essential Thrombocythemia Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 34. United States Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 35. Europe Essential Thrombocythemia Drug Sales Market Share by Company in 2019
Figure 36. Europe Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 37. Europe Essential Thrombocythemia Drug Sales Market Share by Application in 2019
Figure 38. China Essential Thrombocythemia Drug Sales Market Share by Company in 2019
Figure 39. China Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 40. China Essential Thrombocythemia Drug Sales Market Share by Application in 2019
Figure 41. Japan Essential Thrombocythemia Drug Sales Market Share by Company in 2019
Figure 42. Japan Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 43. Japan Essential Thrombocythemia Drug Sales Market Share by Application in 2019
Figure 44. Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Company in 2019
Figure 45. Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 46. Southeast Asia Essential Thrombocythemia Drug Sales Market Share by Application in 2019
Figure 47. India Essential Thrombocythemia Drug Sales Market Share by Company in 2019
Figure 48. India Essential Thrombocythemia Drug Sales Market Share by Type in 2019
Figure 49. India Essential Thrombocythemia Drug Sales Market Share by Application in 2019
Figure 50. AbbVie Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Aop Orphan Pharmaceuticals AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Galena Biopharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Incyte Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Italfarmaco SpA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. MEI Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. PharmaEssentia Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Essential Thrombocythemia Drug
Figure 60. Manufacturing Process Analysis of Essential Thrombocythemia Drug
Figure 61. Essential Thrombocythemia Drug Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
ベルガモットオーガニックエッセンシャルオイルの世界市場レポート2020 Market Analysis and Insights: Global Bergamot Organic Essential Oil Market The global Bergamot Organic Essential Oil market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Bergamot Organic Essential Oil Scope an…- 有機イモーテルエッセンシャルオイルの世界市場レポート2020 Market Analysis and Insights: Global Organic Immortelle Essential Oil Market The global Organic Immortelle Essential Oil market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Organic Immortelle Essential Oil Sc…
- グレープフルーツオーガニックエッセンシャルオイルの世界市場レポート2020 Market Analysis and Insights: Global Grapefruit Organic Essential Oil Market The global Grapefruit Organic Essential Oil market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Grapefruit Organic Essential Oil Sc…
- バジルエッセンシャルオイルの世界市場レポート2020 Market Analysis and Insights: Global Basil Essential Oil Market The global Basil Essential Oil market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Basil Essential Oil Scope and Market Size The global Basil Es…
- ローレルエッセンシャルオイルの世界市場レポート2020 A recently published report by QY Research titled Global Laurel Essential Oil Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…